CRO

Icon banks on translational medicine with U.K. expansion

Icon ($ICLR) is expanding its capacity in the U.K., plotting to set up a 40,000-square-foot translational medicine operation within the Manchester Royal Infirmary Campus' Citylabs. Icon is banking on a boom in translational medicine demand as drug developers seek to understand the relationship between drug exposure and response. Release